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Abstract
Background: Ca
2+ is essential for vesicle fusion with the plasma membrane in virtually all types of regulated exocytoses.
However, in contrast to the well-known effects of a high cytoplasmic Ca
2+ concentration ([Ca
2+]c) in the prefusion phase, the
occurrence and significance of Ca
2+ signals in the postfusion phase have not been described before.
Methodology/Principal Findings: We studied isolated rat alveolar type II cells using previously developed imaging
techniques. These cells release pulmonary surfactant, a complex of lipids and proteins, from secretory vesicles (lamellar
bodies) in an exceptionally slow, Ca
2+- and actin-dependent process. Measurements of fusion pore formation by darkfield
scattered light intensity decrease or FM 1-43 fluorescence intensity increase were combined with analysis of [Ca
2+]c by
ratiometric Fura-2 or Fluo-4 fluorescence measurements. We found that the majority of single lamellar body fusion events
were followed by a transient (t1/2 of decay=3.2 s) rise of localized [Ca
2+]c originating at the site of lamellar body fusion.
[Ca
2+]c increase followed with a delay of ,0.2–0.5 s (method-dependent) and in the majority of cases this signal propagated
throughout the cell (at ,10 mm/s). Removal of Ca
2+ from, or addition of Ni
2+ to the extracellular solution, strongly inhibited
these [Ca
2+]c transients, whereas Ca
2+ store depletion with thapsigargin had no effect. Actin-GFP fluorescence around fused
LBs increased several seconds after the rise of [Ca
2+]c. Both effects were reduced by the non-specific Ca
2+ channel blocker
SKF96365.
Conclusions/Significance: Fusion-activated Ca
2+ entry (FACE) is a new mechanism that leads to [Ca
2+]c transients at the site
of vesicle fusion. Substantial evidence from this and previous studies indicates that fusion-activated Ca
2+ entry enhances
localized surfactant release from type II cells, but it may also play a role for compensatory endocytosis and other cellular
functions.
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Introduction
Ca
2+-triggered membrane fusion is the key element of regulated
exocytosis [1,2]. Multiple Ca
2+-dependent steps have been
elucidated so far, involving molecular motors, cytoskeletal
elements and SNARE proteins that finally lead to the formation
of a fusion pore, an elusive, channel-like structure that represents
the initial connection between vesicle lumen and extracellular
space [3–8]. In fast secreting systems, such as the synaptic
terminal, pore formation and transmitter release follow [Ca
2+]c
elevations after micro to milliseconds only [4]. These systems are
endowed with ‘‘active zones’’, in which complex spatio-temporal
[Ca
2+]c transients, determined by fixed and mobile Ca
2+ buffers,
pumps and exchangers, originate from Ca
2+ entry through
voltage-gated Ca
2+ channels and ‘‘flood’’ the cytoplasm around
subplasmalemmal vesicles at various stages during their rapid
turnover [9,10].
The alveolar type II cell – in contrast – can be defined as a
typical ‘‘slow secreter’’, according to the following features: The
vesicles (lamellar bodies, LBs) are mostly very large (.1 mm), with
no apparent plasmalemmal clustering but rather a scattered
intracellular distribution [11]. Consequently, LBs (between zero
and tens per cell) fuse in a sequential fashion for up to 20 minutes
after stimulation [12]. An overall [Ca
2+]c only moderately above
resting values (near 320 nmol/l) is required to induce LB fusion
with the plasma membrane [13]. Voltage-gated Ca
2+ channels are
not present [14].
The postfusion phase is of particular significance for surfactant
secretion: LBs contain a large and mainly water insoluble complex,
where the laws of single molecule diffusion do not apply [15]. In
addition, fusion pores expand slowly and are a mechanical barrier
to content release [16,17]. As a result, full content release can be
further delayed for minutes to hours, and depends furthermore on
an actin coat that forms around a single LB after fusion [18].
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e10982Although the mechanisms of actin coat contraction have not yet
been studied in detail, Ca
2+ is also required herein, and surfactant
release cannot occur under conditions of increased intracellular
Ca
2+ buffering capacity (e.g. induced by BAPTA-AM) [18].
Although the actual physical forces (in pN) of the actin coat are not
yet known, these features suggest the contribution of an active
contraction to fully expel the vesicle contents.
Considering the delayed actions of Ca
2+, how can agonists like
ATP, which elicits a relatively short-lasting Ca
2+ release from IP3-
sensitive stores (via P2Y2 receptors and activation of PLC) [12],
secrete surfactant from multiple LBs in a sequential fashion,
frequently at times when the Ca
2+ signal is already gone?
To test the hypothesis of ‘‘hidden Ca
2+ signals’’, we investigated
[Ca
2+]c dynamics during all vesicle stages in more detail, taking
advantage of the sequential manner of LB fusion at near basal
overall [Ca
2+]c values. This enabled a mapping of individual
fusion events and [Ca
2+]c on a spatial and temporal basis.
Furthermore, we relied on the power of previously developed
methods that allow precise and reliable determination of fusion
pore formation. One of them, darkfield microscopy of scattered
light intensity decrease (SLID), allows to separate the prefusion
phase from hemifusion and postfusion, combined with the analysis
of [Ca
2+]c during all steps [19]. The data demonstrate unambig-
uously that single LB fusion events are followed by a transient rise
of [Ca
2+]c. The possible modes of activation (mechanical or
chemical) and implications of fusion-activated Ca
2+ entry (FACE)
will be discussed below.
Materials and Methods
Ethics statement
We isolated alveolar type II cells from male Sprague-Dawley
rats (150–200 g) as described [20]. Rats were obtained from
Charles River (Sulzfeld, Germany) and maintained at the central
animal facility of the Ulm University according to institutional
guidelines for ethical care of animals. All experiments in this study
were approved by the Regierungspra ¨sidium Tu ¨bingen, grant Nr.
833.
Cell isolation
Rats were anesthetized (ketamin 10% and xylazil 2%), and
injected with heparin (400 IU/kg). Lungs were perfused, resected,
washed and incubated twice with elastase and trypsin at 37uC for
15 min. Lung tissue was immersed in DNase containing solution
and sliced into ,1 mm bits. Enzyme reaction was stopped by
incubation with FCS (37uC, 2 min). The tissue was filtered 3 times
through gauze and nylon meshes (mesh width: 150, 20, and
10 mm) and the final filtrate centrifuged for 8 min at 1306g. After
suspending in DMEM medium, the cells were put on IgG coated
plastic dishes and incubated at 37uC for 15 min. Non-adherent
cells were centrifuged for 8 min at 1306g, suspended in DMEM
with 10% FCS and 1% Penicillin/Streptomycin (10.000 units/ml
Penicillin, 10 mg/ml Streptomycin in stock solution) and seeded
on glass cover slips. Cells were cultured at 37uC, 5% CO2, and
95% humidity and used for experiments 1–2 days after isolation. 4
Fluo-4 experiments on the darkfield microscope were done on cells
which were frozen in liquid nitrogen immediately after cell
isolation and thawed 2 days before the experiment.
Experimental conditions
Experiments were performed at room temperature in experi-
mental bath solution (in mM: 140 NaCl, 5 KCl, 1 MgCl2,2
CaCl2, 5 glucose, 10 Hepes; pH 7.4). Calcium free bath solution
contained EGTA (2 mM) and no CaCl2. Lamellar body fusion
was stimulated with ATP (100 mM) and phorbol 12-myristate 13-
acetate (PMA; 300 nM) in darkfield/Fluo-4 and with ATP
(10 mM) in FM 1-43/Fura-2 experiments, respectively. Secreta-
gogues were added to the experimental bath solution directly, and
immediately before the start of image acquisition. For the
measurement of [Ca
2+]c, the cells were incubated in DMEM with
5 mM Fluo-4 acetoxymethylester (AM) for 20 min or with 4 mM
Fura-2 AM for 15 min. FM 1-43 was used at 2 mMi n
combination with Fura-2. In control experiments, cells were
preincubated with CellTracker Green CMFDA (5-chloromethyl-
fluorescein diacetate) at 800 nM for 10 minutes. To deplete Ca
2+
stores, the cells were incubated with 150 nM thapsigargin for
20 min. In the experiments with the Ca
2+ channel blocker
SKF96365, 50 mM of this substance was either applied to the
experimental bath solution directly, or the cells were additionally
preincubated with it for 15 min at 37uC. OxiFluor (Oxyrase Inc.,
USA) was added to experimental bath (1:200) in darkfield
experiments to prevent the fluorescence-induced cell damage.
Actin coating of lamellar bodies was measured in cells transfected
with b-actin-GFP adenovirus construct, as described before [18].
All fluorescent dyes were purchased from Molecular Probes
(Invitrogen, Germany).
Fura-2 ratio and FM 1-43 fluorescence imaging
Measurements of FM 1-43 fluorescence in combination with
Fura-2 were performed as described [20]. Using a 2-D imaging
system (TILL Photonics, Germany), cells were illuminated for
20 ms at a rate of 7 Hz at each excitation wavelength (340 and
380 nm for Fura-2; 480 nm for FM 1-43). Excitation light was
deflected by a 520 nm dichroic mirror. In this setting, channel
crosstalk between the FM 1-43 fluorescence and the Fura-2 ratio
would lead to small under-estimations of [Ca
2+]c as described in
detail earlier [13]. To eliminate potential interference with Fura-2
ratio calculations, Fura-2 fluorescence was determined in ring-like
(=peri-vesicular) regions of interest (800 nm wide) surrounding
the fused, FM 1-43 stained LB. Onset of the Ca
2+ rise was
specified as the time-point when the increase in the Fura-2 ratio
exceeded 2-times of its SD within a period of at least 2 seconds.
Ca
2+ spreading was assessed by analyzing Fura-2 ratios (in 0.8–
1 mm wide regions of interest) in 5 and 10 mm linear distances
from the site of fusion for events being sufficiently separated in
time to avoid overlap of spreading Ca
2+ signals from multiple
events. The onset of the Ca
2+ rise at these locations was
determined as described above for the local Ca
2+ increase.
Darkfield and Fluo-4 fluorescence imaging
An upright Richardson RTM 2.5 microscope (Improvision,
Germany) was used for combined darkfield and fluorescence
imaging. For darkfield illumination, a red LP-interference filter
(.620 nm) in the condenser was used together with the RTM 3.0
blue filter cube for fluorescence imaging (490 nm dichroic, 400–
500 nm excitation filter, 510 LP emission filter). Darkfield and
fluorescence light was detected with a 3CCD color video camera
(ExwaveHAD DXC-C33, Sony). All images were acquired with
the 636 Leica water immersion objective (NA=0.90) and
Volocity software (Improvision, Germany). The darkfield and
the fluorescent images were acquired simultaneously and were
digitally separated based on different colors [19].
Image analysis and data presentation
We defined a region of interest encircling the fusing LB in which
darkfield light intensity change was measured. Fluo-4 fluorescence
was measured within a ring-like region of interest surrounding the
fusing LB. The size of selected regions of interest depended on LB
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The lowest value of darkfield and fluorescent measurements was
subtracted and the resulting change in light intensity was expressed
in arbitrary units. Excel 2003 and SigmaPlot 10.0 were used for
statistics and graphs. Unless otherwise stated, data are presented as
mean6standard error of the mean. The alveolar type II cell
photographs were corrected for brightness and contrast with
Adobe Photoshop CS2. The background subtraction was made in
ImageJ by subtracting the first image in an image sequence from
the others with the Image Calculator feature.
Results
To investigate fusion-related Ca
2+ dynamics in single cells, we
combined two independent fusion- and Ca
2+-indicators:
1. FM 1-43 fluorescence with the Fura-2 ratio (Figure 1)
2. SLID with Fluo-4 fluorescence (Figure 2)
In the Fura-2 experiments, LB fusion was detected with FM 1-
43 added to the bath, as outlined in detail previously [16,20]. In
brief, this dye is able to diffuse from the bath through the fusion
pore into the lumen of a fused LB, where the quantum yield of this
dye greatly increases by its interaction with the surfactant bilayers
[21]. This results in a bright localized fluorescence signal. The
Fura-2 ratio was always determined in peri-vesicular regions of
interest (see Materials and Methods).
The Fura-2/FM 1-43 experiments revealed the following:
1. Vesicle fusions were followed by elevations of the peri-vesicular
Fura-2 ratio (Figure 1A and B), its onset being delayed with
regard to the onset in increase of FM 1-43 fluorescence by
239.5631.7 ms (n=49). This indicates that a fusion pore
sufficiently wide to allow FM 1-43 passage preceded the rise of
[Ca
2+]c.
2. The Ca
2+ signal originated at the site of fusion but mostly (in
70% of events where such analysis was possible, n=20)
propagated across the cell. In this case a [Ca
2+]c rise was also
detectable at a distance from the fusion site, however with a
considerable delay (Figure 1C).
3. The incidence of peri-vesicular Fura-2 elevations dropped from
75.4% (n=65) to 16.7% (n=24) when Ca
2+ entry was blocked
in the presence of 1 mM Ni
2+, and was completely abolished
when Ca
2+ was removed from the bath (n=9; Figure 3).
4. FACE was very frequently detected in LB-plasma membrane
fusions, but not in compound (LB-LB) exocytoses (see
Figure 1D; n=10).
The second method for detecting localized Ca
2+ changes at the
time of LB fusion was a combination of Fluo-4 fluorescence and
darkfield microscopy. The latter approach, recently developed in
our lab, is based on the observation that the intensity of scattered
light produced by LBs decreases upon fusion with the plasma
membrane [19]. For most (84.6%) vesicle fusions the decrease
occurred biphasic: The first phase was shown to reflect membrane
lipid merger, whereas the second corresponded to FM 1-43
fluorescence increase and opening of the fusion pore [19]. In the
current study we measured the darkfield light intensity together
with Fluo-4 fluorescence.
The peri-vesicular increase of the Ca
2+ concentration was
measured in a circular 1 mm wide region of interest (Figure 2C).
The start of the Fluo-4 fluorescence onset was determined by
fitting the last 3–12 seconds of the pre-fusion trace, and the first
data point above the noise level in the last 2 seconds of the Fluo-4
recording was taken as the start of fluorescence increase (Figure 2A
and B). Localized increase in [Ca
2+]c was detected in 87.5% of
fusion events (n=24; 21 experiments, 13 cell preparations) and
initiated after the start of the second, steep phase of the scattered
light intensity decrease (SLID2). Previous work showed that the
start of the SLID2 corresponded to the fusion pore opening [19],
therefore the combination of darkfield microscopy and Fluo-4
fluorescence lead to the same conclusion as the combination of FM
1-43 fluorescence and Fura-2 ratio. The mean delay between the
onset of the SLID2 and initiation of localized Fluo-4 fluorescence
increase was 0.59 s60.40 (mean6SD; n=21) which was longer
than the delay between the FM 1-43 fluorescence and the Fura-2
ratio increase. Possible reasons for this discrepancy could be:
N different methods to analyze the instance of fusion pore
opening. Previous work revealed that the onset of FM 1-43
fluorescence may be delayed by up to 0.5 s with regard to
SLID2 or cell membrane capacitance steps, respectively [22].
Although occasions of strongly limited FM 1-43 diffusion
through the pore are not frequent, they tend to underestimate
the delay between pore opening and onset of a Ca
2+ signal.
N different affinities of Fluo-4 (Kd=345nM) and Fura-2
(Kd=224 nM) for Ca
2+ ions
N relatively poor signal to noise ratio in most Fluo-4 experiments
and ensuing uncertainties regarding the precise determination
of a starting point of FACE (Figure 2B).
The localized post-fusion increase in [Ca
2+]c was transient
(Figure 1B and 2D), the median half-time of the decrease in Fluo-4
fluorescence experiments was 3.2 s (interquartile range 2.1–6.5 s;
n=19). The maximum observed half-time of decrease was 26.6 s.
The major reason for the fast Fluo-4 fluorescence decrease in most
experiments is probably photobleaching, which was present
already before the fusion event (Figures 2A and D).
In the majority of fusion events (62.5%), Ca
2+ spread over the
entire cell (Figure 2C and Video S1). The onset of the [Ca
2+]c
increase was measured locally, and 5 and 10 mm away from the
fused LB. The mean delay between onset of SLID2 and that of the
[Ca
2+]c increase was 1.13 s and 1.65 s at 5 and 10 mm,
respectively (n=15, Figure 2E). The calculated mean velocity of
[Ca
2+]c spreading was therefore 9.43 mm/s, which is consistent
with the reported slow diffusion of Ca
2+ ions in the cytoplasm [23]
and confirms results obtained in Fura-2 measurements (10.82 mm/s;
calculated from data in Figure 1C).
An additional indication that a Ca
2+ wave propagated
throughout the cytoplasm starting from one location (the fused
LB), was the measurement of the slope coefficients for the Fluo-4
fluorescence increase. If the [Ca
2+]c increase is actually starting
from a point source in the cell, we would expect these slope
coefficients to be steepest close to the Ca
2+ source and less steep
with increasing distance. A global [Ca
2+]c increase (as caused by a
homogeneous release from stores) should result in similar slope
coefficients throughout the cell. The slope coefficients, calculated
from linear regressions, for the local [Ca
2+]c increase were
significantly higher (1.7061.49; mean6SD; n=21) than those of
the [Ca
2+]c increase 5 mm (1.0360.72; mean6SD; n=18), and
10 mm away from the fused LB (0.6260.50; mean6SD; n=15;
paired t-test, p,0.01; Figure 2F).
To ensure that the localized increase in Fluo-4 fluorescence was
not caused by dye redistribution (although a very unlikely
possibility), we stained the cells with CellTracker Green (CTG),
a cytoplasmic dye, which is not Ca
2+ sensitive and has a molecular
weight that is even smaller than that of Fluo-4 (465 compared to
1097 Da). In measurements combined with darkfield we did not
Fusion-Activated Ca
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PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e10982observe an increase in CTG fluorescence in the vicinity of an LB
at the time of fusion (measured in concentric areas as in Fluo-4
experiments), nor a change in fluorescence 5 and 10 mm away
(n=8; 5 experiments, 4 cell preparations; Figure 2G).
The first question from these experiments is the subcellular
source or even molecular identity of this localized [Ca
2+]c
increase. Fura-2 fluorescence experiments in the absence of bath
Ca
2+ showed the absolute requirement of extracellular Ca
2+ for
the initiation of the localized [Ca
2+]c increase and for the Ca
2+
spreading (Figure 3). To additionally investigate the possible
involvement of intracellular Ca
2+ stores, cells were incubated
with thapsigargin, which inhibits the Ca
2+-ATPase on the
endoplasmic reticulum, thereby depleting internal Ca
2+ stores
[24]. To test the efficiency of thapsigargin treatment we added it
(150 nmol/l) directly to the experimental bath solution under
the microscope. ATP stimulation after 20 min caused no
increase in [Ca
2+]c indicating depleted stores. However, in cells
treated with thapsigargin, 85.7% of vesicle fusions (n=7; 6
experiments, 3 cell preparations) were still accompanied by a
localized [Ca
2+]c increase (in control conditions 87.5%), which
excludes the major role of the endoplasmic reticulum in
initiation and propagation of the Ca
2+ increase (Figure 3, note
that cells had to be stimulated by ATP and PMA: PMA causes
LB fusion without a rise of [Ca
2+]c [25]). On the other hand, the
thapsigargin experiments cannot exclude the contribution of
Ca
2+ ions from IP3-insensitive stores, possibly LBs themselves:
they have high Ca
2+ concentrations, especially those located
near the apical membrane [26]. Ca
2+ transport into LBs is most
likely caused by Ca
2+/H
+ and Ca
2+/K
+ exchangers, whereas
the Ca
2+-ATPase doesn’t seem to play a major role [27].
Therefore, Ca
2+ release by LBs in thapsigargin-treated cells
cannot be entirely ruled out. However, since the removal of
bath Ca
2+ abolished the postfusion [Ca
2+]c increase measured
by Fura-2, it is evident that intracellular stores (IP3 sensitive and
–insensitive) do not contribute to this phenomenon.
Previous work showed that the cytoplasmic Ca
2+ chelator
BAPTA-AM inhibited the actin coat formation around fused
vesicles, as well as surfactant release from LBs [18]. This
observation strongly suggests that localized [Ca
2+]c increase
may assist in actin coat formation and contraction in the course
of surfactant secretion. To test the possible connection between
the post-fusion [Ca
2+]c increase and the actin coating we tried to
block the post-fusion [Ca
2+]c increase with the unspecific Ca
2+
channel blocker SKF96365. By direct application of SKF96365
to the cells, the incidence of the localized post-fusion Fluo-4
fluorescence increase dropped from 87.7% to 35.7% (n=14; 9
experiments, 3 cell preparations, Figure 3). Likewise, in cells
transfected with actin-GFP the incidence of post-fusion actin
coating decreased from 76.3% (n=38; 13 experiments, 10 cell
preparations) to 29.2% (n=24; 8 experiments, 5 cell prepara-
tions, Figure 4A). Pre-incubation of cells with SKF96365 for
15 min at 37uC further decreased the incidence of post-fusion
[Ca
2+]c increase to 9.5% (n=21; 11 experiments, 5 cell
preparations; Figure 3), suggesting that Ca
2+ enters the
cytoplasm through channels. This conclusion is further
strengthened by the observation that 1mM Ni
2+, a non-specific
cation channel blocker, also decreased the incidence of post-
fusion [Ca
2+]c increase to 16.7%. The start of the post-fusion
Ca
2+ influx preceded the start of actin coating for several
seconds (Figure 4B), which excludes the possibility that the
opening of the Ca
2+ channels was caused by rearrangement of
actin cytoskeleton.
Discussion
Methodological aspects
The major new finding of this study is that exocytotic fusion can
trigger Ca
2+ entry. At first glance this is a paradox situation and
contradicts common textbook knowledge that fusion is triggered by
Ca
2+, including the surfactant secreting alveolar type II cell. This
prompts the devil’s advocate to ask the following questions:
N Could our estimations of the instance of fusion pore formation
and rise of [Ca
2+]c be so imprecise that ‘‘hidden [Ca
2+]c
elevations’’ prior to fusion are constantly overseen?
N Could the [Ca
2+]c transients, that we observe, be just random
Ca
2+ release events, similar to Ca
2+ sparks in muscle cells, with
no causal relation to LB fusion?
If Ca
2+ sparks existed in alveolar type II cells, and if our
methods were indeed imprecise, the notion that random Ca
2+
sparks trigger LB fusion events would – in principle – be possible.
However, apart from the fact that our estimates of fusion pore
formation rather tend to underestimate than overestimate the
delay between fusion and [Ca
2+]c rise (see Results), the following
arguments exclude such a scenario:
1. Spontaneous [Ca
2+]c elevations in the absence of LB fusion
events were essentially never observed. Hence, there is no
evidence for the existence of spontaneous, Ca
2+ release events
in alveolar type II cells.
2. Alveolar type II cells have no readily releasable vesicle pool
[13,20]. When cells are stimulated by flash photolysis of caged
Ca
2+, creating a uniform Ca
2+ elevation, the earliest LB fusion
events occur several seconds after the [Ca
2+]c rise [13]. Hence,
even if ‘‘Ca
2+ sparks’’ existed in type II cells, they would not be
able to trigger LB fusion right away.
3. The peak of peri-vesicular [Ca
2+]c increase can be delayed with
respect to fusion pore opening for several seconds (Figure 1B,
2A and 2D). Even if a minor, undetected increase in [Ca
2+]c
would exist already before fusion pore opening, the plain fact
that the major [Ca
2+]c elevation occurs in the postfusion phase
raises questions about the origin, activation and possible role of
this phenomenon.
Figure 1. Fusion-activated Ca
2+ entry measured by Fura-2. (A) Top: Two cells imaged by bright-field (left) and FM 1-43 fluorescence before
(middle) and after (right) fusion of a single LB with the plasma membrane (arrow). Region of interest where the Fura-2 ratio was measured is indicated
by the circles. Bottom: Fura-2 ratio (above) and FM 1-43 fluorescence (below) images from the area within the red square (top left) as a function of
time after cell stimulation with ATP (10 mM). Scale bars: 10 mm (top) and 5 mm (bottom). (B) Time course of the Fura-2 ratio and FM 1-43 fluorescence
measured around and within the area of a single LB during fusion, respectively. Inset shows detailed traces at the time of fusion. The vertical lines
mark the onset of the FM 1-43 fluorescence increase and the start of the Fura-2 ratio increase. (C) Delay of onset of the Fura-2 ratio increase as a
function of the distance from the site of fusion (n=14). The time of the local Fura-2 ratio increase was set to 0 s and the delays 5 and 10 mm distant
from the site of fusion are relative to the time point of the local increase. (D) Image sequence showing LB fusion with the plasma membrane
(detected by FM 1-43 staining; upper row), followed by fusion of a second LB to the already fused one (=compound exocytosis; bottom row). The
graph on the right shows FM 1-43 fluorescence increase for both fusions (marked in red and green on the right image sequence) together with the
Fura-2 ratio change around the fusing LB.
doi:10.1371/journal.pone.0010982.g001
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misinterpretation caused by possible dye accumulation in LBs,
which would measure extracellular Ca
2+ following fusion pore
formation, can be excluded for the following reasons:
1. The signal spread within the borders of a cell exclusively, and
not into the outside of the cell, as would be the case if Ca
2+-
sensitive dye was secreted along with surfactant material (see
also Figure S1).
2. LBs contain a high (mM) Ca
2+ concentration prior to fusion
[26]. Hence, in case of dye accumulation, they should appear
bright, not dark, excluding a possibility that the LBs contain
large quantities of the dye.
3. Video S1 clearly demonstrates that the fluorescence intensity
increase after fusion occured around, not within, LBs.
Origin of FACE
Less clear than the mere fact that fusion triggers [Ca
2+]c
elevations, is the question of its origin: does Ca
2+ come from the
extracellular space exclusively, or also from the fusing LB?
However, the distinction between LB and extracellular space is -
in this context - somewhat semantic, because during the postfusion
phase, the lumen of the LB is by definition part of the extracellular
space (see below and Figure 5).
A similar problem refers to the notion of ‘‘Ca
2+ entry’’ vs. ‘‘Ca
2+
release’’. Conventionally, ‘‘Ca
2+ entry’’ refers to Ca
2+ entering the
cytoplasm from the extracellular space, whereas Ca
2+ release
denotes Ca
2+ coming from intracellular stores. Naturally, IP3-
insensitive Ca
2+ stores may exist that also contribute to the [Ca
2+]c
rise, including the LB itself. However, considering all evidence
(abolishment by removal of bath Ca
2+, ineffectiveness of
thapsigargin), it is reasonable to assume that the crucial origin of
Ca
2+ is the extracellular space, for which ‘‘fusion-activated Ca
2+
entry’’ (FACE) is the appropriate term. Ca
2+-induced Ca
2+ release
may be an amplification mechanism that applies particularly for
those cells, in which the signal spreads to sites remote from the
location of fusion.
Recently, Chintagari et al. [28] showed that inhibition by
bafilomycin A1 of the V-ATPase on the LB membrane causes
Ca
2+ release from LBs. If Ca
2+ stored in LBs was the major source
of FACE, it should be greatly blocked by this drug, which depletes
this store. However, we found that pretreatment with bafilomycin
A1 (20 nM for 1h at 37uC) could not inhibit FACE (3 of 4 fusion
events were followed by FACE, data not shown). This further
strengthens the notion that the major part of Ca
2+ comes from the
extracellular space (possibly through the fused LB, see Figure 5), a
pathway for which the term ‘‘Ca
2+ entry’’ is most appropriate.
Pathway(s) and mode of activation of FACE
This is largely a matter of speculation. FACE appears to be
independent of the mode of cell stimulation: It occurred after
submaximal stimulation with ATP, after maximal stimulation with
ATP plus phorbol ester (see above) and also after stimulation of
protein kinase A (with 20 mM terbutaline and 5 mM forskolin, in 3
of 4 fusion events, data not shown). Evidence suggesting that an
ion channel is involved arises from the time-dependent inhibition
by SKF96365 and from inhibition by Ni
2+ ions. SKF96365 is a
broad inhibitor of various TRP channels [29–32]. Preincubation-
time dependent inhibition in fact suggests that the majority of
FACE does not occur through the plasma membrane, but through
Figure 2. Fusion-activated Ca
2+ entry in darkfield and Fluo-4 experiments and propagation of the local Ca
2+ increase. (A) Decrease in
darkfield light intensity at the time of fusion (filled squares) mostly occurred in 2 phases. Phase 1 (slow decrease) was shown in a previous study to
reflect lipid mixing (left dashed line), phase 2 (steep decrease) was shown to reflect fusion pore opening (right dashed line). The start in Fluo-4
fluorescence increase (open squares) corresponded to the start of phase 2 in darkfield light decrease. We confirmed that the darkfield events indeed
represented fusion of the LB with the plasma membrane by observing surfactant squeezing through the fusion pore in darkfield light (n=12) or by
subsequent staining of the fusion events with FM 1-43 (n=11). (B) To determine the start of the Fluo-4 fluorescence increase the pre-fusion part of
the fluorescence data was fitted by a linear regression (solid line). The first data point which exceeded the noise level of the last 2 s before the fusion
(dotted line) was taken as the starting point. (C) Alveolar type II cell in darkfield and fluorescence during one LB fusion event with the plasma
membrane, stimulated by ATP (100 mm) and PMA (300 nM; arrowhead). The bottom row shows the subtracted Fluo-4 fluorescence images (the first
fluorescence image was subtracted from all others). Note the localized Fluo-4 increase at 3 s and the subsequent spreading over the cell. The start of
the phase 2 in the darkfield recording was at 1.8 s (see graph on Figure 3D). The fusing vesicle appears darker as the others, which might happen if
LBs contain a minor amount of Fluo-4, which can diffuse out of the vesicle when the fusion pore is open (see also Video S1). Scale bar=8 mm. (D) The
decrease in darkfield light intensity (red) together with Fluo-4 fluorescence measured locally (blue), 5 mm (violet) and 10 mm (orange) from the site of
the fusion event shown in C. The green line indicates Fluo-4 fluorescence measured 10 mm from the vesicle outside the cell (see Figure S1). Times in D
correspond to the ones in C. The dashed line indicates the start of phase 2 in the darkfield recording and k indicates the slope coefficient of Fluo-4
increase. (E) Delay of onset of the Fluo-4 fluorescence increase (n=15) as a function of the distance from the site of fusion. The time of the local Fluo-
4 fluorescence increase was set to 0 s and the delays 5 and 10 mm distant from the site of fusion are relative to the time point of the local increase. (F)
Comparison of the slope coefficients for the Fluo-4 fluorescence increase measured at different distances from the site of fusion. (G) Example of LB
fusion in an alveolar type II cell stained with CellTracker Green (CTG), a Ca
2+ insensitive dye. CTG fluorescence around the fusing LB did not change at
the time of fusion. The general decrease of fluorescence before fusion in D and G was due to photobleaching.
doi:10.1371/journal.pone.0010982.g002
Figure 3. Incidence of FACE and Ca
2+ spreading over the cell in
different experimental conditions. FACE (black bars) and Ca
2+
spreading over the cell (gray bars) were measured with Fura-2 and Fluo-
4. Note that the removal of Ca
2+ from the bath solution (Ca-free)
abolished the localized Ca
2+ increase, whereas the treatment with
thapsigargin (Thapsi) did not have an effect. Treatment with nickel
(1mM Ni
2+), direct addition of the Ca
2+ channel blocker SKF96365 (SKF),
or pretreatment of the cells with it (SKF preincubated) decreased the
incidence of FACE, suggesting the involvement of Ca
2+ channels in the
initiation of the localized Ca
2+ increase. Cells were stimulated for
secretion with 10 mM ATP in Fura-2 experiments and with 100 mM ATP
and 300 nM PMA in Fluo-4 experiments.
doi:10.1371/journal.pone.0010982.g003
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2+ entered through the plasma
membrane, the effect of SKF96365 should not depend so strictly
on its incubation time. The slow action rather suggests a long
diffusion path to reach a channel inside the LB. On the other
hand, Ni
2+ is not membrane permeable and should only block
those channels that are directly exposed to the extracellular space.
Both inhibitors had a strong effect on the incidence of FACE,
however possible differences in their targets as well as the
observation that none of them could completely inhibit FACE,
do not allow for a clear conclusion about the nature and
localization of putative Ca
2+ channels.
Also speculative are possible modes of activation of FACE. Two
mechanisms are most likely:
N mechanical (‘‘membrane stress’’)
N chemical (‘‘membrane merger’’)
Mechanical activation. The strongest argument in favor of a
mechanical mode of activation is LB swelling. Many secretory
vesicles swell after fusion through osmotic uptake of water by the
vesicle matrix [33], and postfusion LB swelling is considerable,
with volume increases up to .20% [19]. However, postfusion
vesicle swelling is not necessarily associated with stretch (and stress)
of its limiting membrane, because membrane tension can cause a
replenishing lipid flow from the plasma membrane to the vesicle
membrane, increasing the membrane area [34]. The membrane
stress hypothesis is therefore conceivable under either of the
following conditions:
1. The fusion pore is a significant barrier for free lipid flow from
the plasma into the LB membrane, such that swelling-induced
LB membrane stress occurs. Recent observations of lipid-
anchored fluorophore diffusion measurements suggest that this
may be the case [19].
2. LB swelling leads to ion channel activation by channel-
cytoskeleton interactions.
Since both conditions are possible, mechanical activation of
FACE is a reasonable working hypothesis.
Chemical activation. Recent studies indicate that lipid
merger between the plasma and vesicle membranes cause
translocation of lipid mediators and activation of signaling
cascades that finally induce actin assembly [35–37]. Any of such
Figure 4. Correlation between post-fusion actin coating and
localized Ca
2+ entry. (A) Incidence of fusion events followed by actin
coating and surfactant release in control conditions and after addition of
SKF96365 to the bath. (B) The temporal relationship between localized
Ca
2+ increase and actin coating of the fused vesicles. Fluo-4 fluorescence
data (n=11) were acquired at 5/s and the actin-GFP fluorescence of
fusing vesicles (n=29) at 10/min. The start of the darkfield light decrease
(designating fusion pore opening) was set to the time point 10 s (dashed
line). Cells were stimulated for secretion with 100 mM ATP and 300 nM
PMA added directly to the experimental bath.
doi:10.1371/journal.pone.0010982.g004
Figure 5. Possible pathways of FACE. (A) Ca
2+ entry into the cytoplasm through channels located on the plasma membrane. (B) Ca
2+ entry into
the cytoplasm through channels located on the LB membrane. Here Ca
2+ entry occurs in series with the fusion pore, with the consequence that the
amount of Ca
2+ entering the cytosol could be a function of fusion pore permeability, LB membrane permeability and amount of Ca
2+ ions stored
inside the LB. In both cases, A and B, channel activation may occur mechanically (membrane stress) or chemically (membrane merger; see also
Discussion). The relative contribution of each model to FACE is yet unknown. In addition, intracellular amplification of the FACE-induced Ca
2+ signal
by Ca
2+-induced Ca
2+ release may take place.
doi:10.1371/journal.pone.0010982.g005
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activation of a Ca
2+ channel.
Possible functions of FACE
Since the [Ca
2+]c elevation caused by FACE in most cases
spread out through the entire cell (see Results), the whole spectrum
of Ca
2+-dependent functions could be envisaged. Owing to its
localized origin, however, and a large body of additional evidence,
the following 3 functions are most likely for alveolar type II cells:
N Actin coat formation and surfactant release
N Endocytosis
N Activation of adjacent LBs, possibly for inducing compound
exocytosis
Actin coat formation and surfactant release. Awareness is
growing that postfusion regulation of content release may be
relevant to cell physiology in various types of secretion (recently
reviewed in Ref. [38]). Beside the known effects of Ca
2+ and
protein kinase C on fusion pore expansion [16,39], recent
evidence supports a role of molecular motors, such as F-actin
and myosin 2 phosphorylation, for fusion pore and vesicle
dynamics [38]. We have previously shown that single LB fusion
events with the plasma membrane trigger the formation of a
locally restricted actin-GFP coat around the fused LB [18]. This
coat is likely necessary for LB ‘‘contraction’’ and surfactant release
into the extracellular space (the term ‘‘contraction’’ denotes an
apparent squeezing-out of surfactant through the fusion pore,
although contractile forces of this coat have not yet been directly
measured). Since actin coat formation occurs clearly after FACE
(Figure 4B), a dependence of actin coat formation (and surfactant
release) on FACE (and not vice versa) is strongly suggested. We
therefore aimed at further testing this hypothesis applying a non-
specific, broadly acting Ca
2+ channel inhibitor (SKF96365).
Inhibition of both, FACE and actin coat formation, by this drug
strengthens the notion that a major physiological role of FACE
could be the facilitation of LB contraction and surfactant release.
This function may gain particular importance if the fusion pore
does not fully expand and remains a physical barrier for release, as
demonstrated earlier [16,17]. Experiments elevating [Ca
2+]c with
the Ca
2+ ionophore ionomycin showed that fusion pore expansion
is enhanced by an increased Ca
2+ concentration [16]. Therefore it
is conceivable that FACE could also promote the fusion pore
enlargement and content release. The mechanisms of actin coat
formation are complex and have been discussed in detail by others
[40]. However, the role of Ca
2+ and the identity of molecular
effectors involved in this process remain an open question. In
addition, FACE may not only contribute to actin assembly, but
also to active force generation and content release.
Endocytosis. The compensatory membrane retrieval after
vesicle fusion is thought to depend on cytoplasmic Ca
2+ (e.g. [41]).
In previous work on postfusion actin coating, we demonstrated
that the whole LB together with its contents can be retrieved (‘kiss
and run’ events), which was not observed under conditions of Ca
2+
chelation with BAPTA-AM. Hence, kiss-and-run events might be
influenced by FACE as well. In see urchin eggs Ca
2+ influx
necessary for endocytosis was mediated by P-type Ca
2+ channels
[42]. However, this mechanism is unlikely in type II pneumocytes,
because they lack voltage-gated Ca
2+ currents, in resting state as
well as during all stages of exocytosis [14].
Activation of neighboring LB fusion. Since the threshold
[Ca
2+]c for LB fusion with the plasma membrane is very low [13],
FACE should be able to contribute to LB fusions. In alveolar type
II cells, subsequent LB fusions at sites very close to each other are
frequently observed, and cell degranulations often appear to
proceed like a ‘‘chain reaction’’ rather than a simultaneous event
[25], consistent with other cell types [43]. It is not clear, if
homotypic LB-LB fusion is activated by Ca
2+ to the same extent as
heterotypic LB-plasma membrane fusion. Nevertheless, the
localized origin of FACE in conjunction with the strong Ca
2+-
dependence of LB fusion with the plasma membrane strongly
suggests that FACE stimulates subsequent LB fusions at a closely
located site. Hence, FACE could be a mechanism which
contributes to increased, localized secretion, possibly compound
exocytosis.
Summary
In this study, we have identified a new Ca
2+ entry mechanism
(FACE). Its molecular pathway(s) and mode(s) of activation remain
to be elucidated. Owing to common principles of exocytosis
(membrane merger, vesicle swelling, etc.), FACE may also play an
important role in other secretory cell types, in which time and
space-resolved resolution of exocytotic fusion and Ca
2+ dynamics
are more difficult to detect than in the pulmonary alveolar type II
cells.
Supporting Information
Figure S1 Fluo-4 fluorescence increase after vesicle fusion was
only detected on the area of the exocytosing cell. Left: Regions of
Fluo-4 measurements. Orange circle: within the cell, green circle:
outside the cell (see main text and Figure 2C). The fusing vesicle is
marked by an arrow. Right: Fluorescence change within both
areas at the time of fusion. There was a considerable increase in
intracellular Fluo-4 fluorescence but no increase at the same
distance from the fusing vesicle outside the cell. Therefore, the
fluorescence signal was caused by intracellular spreading of Ca2+
and not by redistribution of extracellular dye, excluding a possible
misinterpretation of the data.
Found at: doi:10.1371/journal.pone.0010982.s001 (0.90 MB TIF)
Video S1 Subtracted Fluo-4 fluorescence video for the fusion
event shown in Figure 2C and D. The video is 9 s long and
encompasses the time window shown in Figure 2D. The first,
subtracted, black image in the image sequence is not shown. Note
the localized nature of the fluorescence increase at the time of
fusion and the subsequent spreading over the cell.
Found at: doi:10.1371/journal.pone.0010982.s002 (6.60 MB AVI)
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